Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RENT.COM.AU LIMITED Share Issue/Capital Change 2003

Dec 15, 2003

65722_rns_2003-12-15_a0bd0b81-6060-40d2-83bd-c650b9bd0e36.pdf

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

New issue announcement, application for quotation of additional securities and agreement

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 1/7/96. Origin: Appendix 5. Amended 1/7/98, 1/9/99, 1/7/2000, 30/9/2001, 11/3/2002, 1/1/2003.

Name of entity

SELECT VACCINES LIMITED

ABN

25 062 063 692

We (the entity) give ASX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).

$\pmb{\mathbb{I}}$ 'Class of 'securities issued or to be Options issued

  • $\overline{2}$ Number of 'securities issued or to 350,000 be issued (if known) or maximum number which may be issued
  • 3 Principal terms of the 'securities (eg, if options, exercise price and expiry date; if partly paid securities, the amount outstanding and due dates for payment; if convertible securities, the conversion price and dates for conversion)

Options, exercisable at \$0.20 on or before 31

May 2008 (SLTOA)

+ See chapter 19 for defined terms.

4 Do the securities rank equally in all
respects from the date of allotment
with an existing class of quoted
securities?
Yes, upon exercise
If the additional securities do not
rank equally, please state:
the date from which they do
٠
extent to
which
the
they
participate for the next dividend,
(in
the
case
οf
a
trust.
distribution) or interest payment
the extent to which they do not
rank equally, other than in
relation to the next dividend,
distribution or interest payment
5 Issue price or consideration \$0.30
6 Purpose of the issue
(If issued as consideration for the
acquisition of assets, clearly identify
those assets)
In lieu of payment of fees.
7 Dates of entering 'securities into
uncertificated
holdings
or
despatch of certificates
16 December 2003
Number Class
8 Number and 'class of all 'securities
quoted on ASX (including the
securities in clause 2 if applicable)
21,630,971 Ordinary
Shares
(SLT)
7,637,987 Options exercisable at
\$0.80 on or before 1
February
2007
(SLTO)
6,255,837
Options exercisable at
\$0.20 on or before 31
May 2008 (SLTOA)

$\pm$ See chapter 19 for defined terms.

Number Class
9 Number and 'class of all securities
not quoted on ASX (including the
3,000,000 Shares,
Ordinary
escrowed until 3 July
securities in clause 2 if applicable) 2005 (SLTAI)
6,750,000 Options exercisable at
$$0.20$ on or before $31$
may 2008, escrowed
until $3$ July
2005
(SLTAM)
2,000,000
Options exercisable at
$$0.20$ on or before $30$
June 2006, escrowed
until $27$ June $2004$
(SLTAK)
10 Dividend policy (in the case of a
twent distribution antiout on the
Unchanged

trust, distribution policy) on the increased capital (interests)

Part 2 - Bonus issue or pro rata issue

Ħ security
approval
holder
Is.
required?
12 Is the issue renounceable or non-
renounceable?
13 Ratio in which the securities will be
offered
4 Class of securities to which the
offer relates
15 determine
Record
date
to
entitlements
16 Will holdings on different registers
(or subregisters) be aggregated for
calculating entitlements?
17 Policy for deciding entitlements in
relation to fractions

$+$ See chapter 19 for defined terms.

Appendix 3B
New issue announcement

18 Names of countries in which the
entity has 'security holders who will
not be sent new issue documents
Note: Security holders must be told how their
entitlements are to be dealt with.
Cross reference: rule 7.7.
19. Closing
date
for
of
receipt
acceptances or renunciations
20. Names of any underwriters
21 Amount of any underwriting fee or
commission
22. Names of any brokers to the issue
23. Fee or commission payable to the
broker to the issue
24 any handling
Amount
of
fee
payable to brokers who lodge
acceptances or renunciations on
behalf of 'security holders
25. If the issue is contingent on
security holders' approval, the date
of the meeting
26.
Date entitlement and acceptance
form and prospectus or Product
Disclosure Statement will be sent to
persons entitled
27 If the entity has issued options, and
the terms entitle option holders to
participate on exercise, the date on
which notices will be sent to option
holders
28.
Date rights trading will begin (if
applicable)
29. Date rights trading will end (if
applicable)
30 How do security holders sell their
entitlements in full through a
broker?

How do security holders sell $part$
of their entitlements through a $31\,$ broker and accept for the balance?

$\pm$ See chapter 19 for defined terms.

  • 32 How do 'security holders dispose of their entitlements (except by sale through a broker)?
  • 33 Despatch date

Part 3 - Quotation of securities

You need only complete this section if you are applying for quotation of securities

34 Type of securities $(iick one)$ $(a)$ Securities described in Part 1 $(b)$ All other securities

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issuel on expiry or conversion of convertible securities

Entities that have ticked box 34(a)

Additional securities forming a new class of securities

Tick to indicate you are providing the information or documents

  • 35 If the 'securities are 'equity securities, the names of the 20 largest holders of the additional securities, and the number and percentage of additional securities held by those holders
  • If the securities are 'equity securities, a distribution schedule of the additional 36 securities setting out the number of holders in the categories $1 - 1,000$ $1,001 - 5,000$ $5,001 - 10,000$ 10,001 - 100,000 100,001 and over

37

A copy of any trust deed for the additional securities

+ See chapter 19 for defined terms.

Entities that have ticked box 34(b)

  • 38 Number of securities for which quotation is sought
  • 39 Class of securities for which quotation is sought
  • 40 Do the securities rank equally in all respects from the date of allotment with an existing class of quoted securities?

If the additional securities do not rank equally, please state:

  • the date from which they do
  • the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment
  • the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment
  • 41 Reason for request for quotation now

Example: In the case of restricted securities, end of restriction period

(if issued upon conversion of another security, clearly identify that other security)

42 Number and class of all securities quoted on ASX (including the securities in clause 38)

Number Class

+ See chapter 19 for defined terms.

Ouotation agreement

  • Quotation of our additional securities is in ASX's absolute discretion. ASX may $\mathbf{I}$ quote the securities on any conditions it decides.
  • $\overline{2}$ We warrant the following to ASX.
  • The issue of the securities to be quoted complies with the law and is not for an illegal purpose.
  • There is no reason why those 'securities should not be granted 'quotation. $\bullet$
  • An offer of the "securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

  • Section 724 or section 1016E of the Corporations Act does not apply to any ٠ applications received by us in relation to any securities to be quoted and that no-one has any right to return any 'securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the securities be quoted.
  • We warrant that if confirmation is required under section 1017F of the Corporations Act in relation to the securities to be quoted, it has been provided at the time that we request that the securities be quoted.
  • If we are a trust, we warrant that no person has the right to return the ٠ securities to be quoted under section 1019B of the Corporations Act at the time that we request that the securities be quoted.

+ See chapter 19 for defined terms.

  • $\overline{3}$ We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.
  • $\overline{4}$ We give ASX the information and documents required by this form. If any information or document not available now, will give it to ASX before guotation of the securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

Sign here:

Company Secretary

Date: 16 December 2003

Print name:

Phillip Hains

$\equiv$ $\equiv$ $\equiv$ $\equiv$

+ See chapter 19 for defined terms.